ASAIO J 2021 Sep 20. Epub 2021 Sep 20.
From the Department of Intensive Care, CHU Lille, Lille, France University of Lille, Inserm U1167, Institut Pasteur de Lille, Lille, France Department of Cardiovascular Surgery, CHU Lille, Lille, France Cardiovascular Intensive Care Unit, CHU Lille, Lille, France University of Lille, Inserm U1011, Institut Pasteur de Lille, EGID, Lille, France Emergency Department and SAMU, CHU Lille, Lille, France University of Lille, Inserm U1285, CNRS UMR 8576, Lille, France.
Selecting patients most likely to benefit from venoarterial extracorporeal membrane oxygenation (V-A ECMO) to treat refractory drug-induced cardiovascular shock remains a difficult challenge for physicians. This study reported short-term survival outcomes and factors associated with mortality in V-A ECMO-treated patients for poisoning. Twenty-two patients placed on V-A ECMO after drug intoxication from January 2014 to December 2020 were retrospectively analyzed. Read More